|Last Price$27.13||Day Change (%)-0.22%|
|Open Price$27.33||Day Change ($)-0.06|
|Day Range26.71–27.79||52-Week Range26.04–42.96|
As of Wed 04/16/2014 03:44 PM EST | USD
Clinigen Group Acquires Oncology Support Therapy SAVENE® (dexrazoxane) from SpePharm AG
Theravance THRX reported second-quarter earnings that matched our expectations, and we are keeping our fair value estimate at $29 per share. The company continues to make progress in each of its programs, namely the addition of a second Phase IIb compound in the Beyond Advair trials and completion ...